Shalina Healthcare
Mukesh Agarwal has extensive work experience in finance and business development. Mukesh is currently the Group CFO at Shalina Healthcare since January 2022. Prior to that, they served as the Head of Finance, Emerging Markets at Viatris from November 2020 to January 2022. Mukesh also held various roles at Pfizer, including Head of Finance, Emerging Markets, Upjohn Business from December 2018 to November 2020, and Senior Regional Finance Director, Africa Middle East from January 2017 to November 2018. Before joining Pfizer, Agarwal worked at Bristol-Myers Squibb, where they held positions such as Head of Finance, Middle East Africa and India from July 2015 to December 2016, and India CFO from November 2011 to June 2015. Mukesh also has experience in business development roles at Slam Dunk Networks, Corio (acquired by IBM), Oracle, and the Mitchell Madison Group. Agarwal started their career as an Associate at Booz Allen & Hamilton.
Mukesh Agarwal earned an MBA in Finance from Columbia Business School in 1995. Prior to that, they received a Certified Public Accountant (CPA) designation in the USA in 1990. In 1989, they obtained a Master of Accounting degree from East Tennessee State University. As a foundation, they completed their education with a Chartered Accountant designation from the Institute of Chartered Accountants of India in 1987.
This person is not in any offices
Shalina Healthcare
1 followers
Shalina Healthcare is a market leader in making quality healthcare products affordable and available across Africa. We achieve this by sourcing from WHO-approved production facilities in India and China and by focusing on our first-class distribution expertise. Shalina Healthcare is privately owned and part of the Shalina Group. We have been operating in Africa for more than thirty years. The Shalina Group is headquartered in Dubai and we have operating offices in Nigeria, Zambia, The Democratic Republic of Congo, Angola, Ghana, Republic of South Sudan, Kenya, Cameroon, Central African Republic, India and China. We employ over one thousand people worldwide. Shalina Group’s second business vertical is Shalina Resources, a minerals company located in Southern DRC. Shalina Healthcare is a market leader and we offer a wide basket of more than two hundred and fifty products. We participate in both the prescription and over-the-counter categories in a broad range of therapeutic groups, including anti-malarials, antibiotics, anti-inflammatory and nutrition. Our range includes both generic and branded generic products. Shalina Healthcare also offers a range of consumer products in the hygiene segment, most notable with our brand Germol. Our reputation as reliable manufacturers and distributors of healthcare products is reinforced every time we launch a new product into the market. It may be the first time the drug has been launched in the remote regions that we serve and we support this with regular continuing medical education campaigns for the doctors and nurses. Over the last thirty years, Shalina's reputation as a quality healthcare provider in Africa has been well accepted by the medical community, who has no hesitation in prescribing Shalina products to their patients. We work closely with the local communities to help people live longer and healthier lives. None of this would be possible without the immense contribution of our dedicated employees.